Difenacoum

CAS: 56073-07-5

Ref. 3D-FD01490

Produktinformation

• Name: Difenacoum
• Synonyme: 3-(3-p-Diphenyl-1,2,3,4-tetrahydronaphth-1-yl)-4-hydroxycoumarin3-(3-Biphenyl-4-yl-1,2,3,4-tetrahydro-naphthalen-1-yl)-4-hydroxychr omen-2-one, 2-Hydroxy-3-[3-(4-Phenylphenyl)-1,2,3,, 2H-1-Benzopyran-2-one, 3-(3-[1,1′-biphenyl]-4-yl-1,2,3,4-tetrahydro-1-naphthalenyl)-4-hydroxy-, 3-(3-(1,1'-Biphenyl)-4-yl-1,2,3,4-tetrahydro-1-naphthalenyl)-4-hydroxy-2H-1-benzopyran-2-one, 3-(3-Biphenyl-4-Yl-1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxycoumarin, 3-(3-p-Diphenyl-1,2,3,4-tetrahydronaphth-1-yl) -4-hydroxycoumarin, 3-[3-(biphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-2-hydroxy-4H-chromen-4-one, 3-[3-(biphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-hydroxy-2H-chromen-2-one, 4-Tetrahydronaphthalen-1-Yl]Chromen-4-One, Coumarin, 3-(3-(4-Biphenylyl)-1,2,3,4-Tetrahydro-1-Naphthyl)-4-Hydroxy-, Difenakum, Diphenacoum, Neosorexa, Ratak
• CAS: 56073-07-5

Beschreibung

Difenacoum is a synthetic cannabinoid that is produced by the asymmetric synthesis of coumarin derivatives. It has been shown to bind to fibrinogen and inhibit the activity of the enzyme thrombin, which is involved in blood coagulation. Difenacoum has also been shown to affect liver cells and human serum. This drug has an analytical method that includes electrochemical impedance spectroscopy (EIS) as well as LC-MS/MS for chemical analysis. Difenacoum can be found in wastewater treatment effluents and wild-type mice have been used to study its pharmacokinetic properties.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 444.52 g/mol
• Formel: C₃₁H₂₄O₃
• Reinheit: Min. 95%
• InChl: InChI=1S/C31H24O3/c32-30-26-12-6-7-13-28(26)34-31(33)29(30)27-19-24(18-23-10-4-5-11-25(23)27)22-16-14-21(15-17-22)20-8-2-1-3-9-20/h1-17,24,27,32H,18-19H2
• InChI Key: InChIKey=FVQITOLOYMWVFU-UHFFFAOYSA-N
• SMILES: O=c1oc2ccccc2c(O)c1C1CC(c2ccc(-c3ccccc3)cc2)Cc2ccccc21